National Health (Pharmaceutical Benefits Early Supply) Amendment Instrument 2015 (No. 7) specification under subsection 84AAA(2) (PB 81 of 2015) (Cth)

PB 81 of 2015

National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2015 (No. 7) – specification under subsection 84AAA(2)

National Health Act 1953

I, KYLIE JONASSON, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated         25 August 2015

KYLIE JONASSON

First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health

___________________________________________________________________________

Amendment determination – Pharmaceutical Benefits – Early Supply

1          Name of Instrument

(1)   This Instrument is the National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2015 (No. 7) – specification under subsection 84AAA(2).

(2)This Instrument may also be cited as PB 81 of 2015.

2          Commencement

This Instrument commences on 1 September 2015.

3          Amendment of PB 30 of 2009

Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009 – specification under subsection 84AAA(2) (PB 30 of 2009).

Schedule 1        Amendments

1. Schedule 1, after entry for Famotidine in the form Tablet 40 mg

insert:

Febuxostat Tablet 80 mg Oral 28 5